Compare ICE & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ICE | NUWE |
|---|---|---|
| Founded | 2000 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.5B | 2.9M |
| IPO Year | 2005 | N/A |
| Metric | ICE | NUWE |
|---|---|---|
| Price | $163.02 | $2.27 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $194.70 | N/A |
| AVG Volume (30 Days) | ★ 3.5M | 51.0K |
| Earning Date | 10-30-2025 | 11-12-2025 |
| Dividend Yield | ★ 1.18% | N/A |
| EPS Growth | ★ 30.10 | N/A |
| EPS | ★ 5.49 | N/A |
| Revenue | ★ $9,750,000,000.00 | $8,167,999.00 |
| Revenue This Year | $7.73 | N/A |
| Revenue Next Year | $5.52 | $10.48 |
| P/E Ratio | $29.73 | ★ N/A |
| Revenue Growth | ★ 6.48 | N/A |
| 52 Week Low | $142.29 | $2.02 |
| 52 Week High | $189.35 | $70.14 |
| Indicator | ICE | NUWE |
|---|---|---|
| Relative Strength Index (RSI) | 65.88 | 42.84 |
| Support Level | $155.76 | $2.24 |
| Resistance Level | $159.31 | $2.86 |
| Average True Range (ATR) | 2.17 | 0.21 |
| MACD | 0.97 | 0.05 |
| Stochastic Oscillator | 91.52 | 30.95 |
Intercontinental Exchange is a vertically integrated operator of financial exchanges and provides ancillary data products. Though the company is probably best known for its ownership of the New York Stock Exchange, which it acquired in 2013, ICE operates a large derivatives exchange, too. The company's largest commodity futures product is the ICE Brent crude futures contract. In addition to the exchanges business, which is about 54% of net revenue, Intercontinental Exchange has used a series of acquisitions to create its mortgage technology business (22% of net revenue) and fixed-income and data services segment (24% of net revenue).
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.